Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.

Nat Commun · 2022 · PMC9051102 · PMID 35484100

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

No cytotoxic activity of UCART123 was elicited against Daudi cells, while there was a clear trend towards increasing degranulation, cytotoxic activity and IFNγ release by CART cells against AML cell lines with low, medium and high CD123 levels (Supplementary Fig. 3 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.